These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10988340)

  • 1. Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition.
    Verhagen AM; Hohbach J; Joles JA; Braam B; Boer P; Koomans HA; Gröne H
    Eur J Pharmacol; 2000 Jul; 400(2-3):239-47. PubMed ID: 10988340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
    Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
    Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H+-ATPase activity on unilateral ureteral obstruction: interaction of endogenous nitric oxide and angiotensin II.
    Valles PG; Manucha WA
    Kidney Int; 2000 Oct; 58(4):1641-51. PubMed ID: 11012898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
    Therrien F; Lemieux P; Bélanger S; Agharazii M; Lebel M; Larivière R
    Eur J Pharmacol; 2009 Apr; 607(1-3):126-34. PubMed ID: 19326569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats.
    Symons JD; Stebbins CL; Musch TI
    J Appl Physiol (1985); 1999 Aug; 87(2):574-81. PubMed ID: 10444615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
    D'Amours M; Lebel M; Grose JH; Larivière R
    Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition.
    Verhagen AM; Rabelink TJ; Braam B; Opgenorth TJ; Gröne HJ; Koomans HA; Joles JA
    J Am Soc Nephrol; 1998 May; 9(5):755-62. PubMed ID: 9596072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition.
    Turkstra E; Braam B; Koomans HA
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):593-600. PubMed ID: 9781927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats.
    Kucuk M; Kaya M; Kalayci R; Cimen V; Kudat H; Arican N; Elmas I; Korkut F
    Life Sci; 2002 Jul; 71(8):937-46. PubMed ID: 12084390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain AT(2) receptor mediate vasodepressor response to footshocks: role of kinins and nitric oxide.
    Israel A; Sosa B; Gutierez CI
    Brain Res Bull; 2000 Mar; 51(4):339-43. PubMed ID: 10704785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
    Matsuhisa S; Otani H; Okazaki T; Yamashita K; Akita Y; Sato D; Moriguchi A; Imamura H; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2473-9. PubMed ID: 18390819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
    Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
    Qiu C; Baylis C
    Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of angiotensin II receptors in the portosystemic collaterals of portal hypertensive and cirrhotic rats.
    Huang HC; Chang CC; Wang SS; Lee FY; Teng TH; Lee JY; Lin HC; Chuang CL; Lee SD
    J Vasc Res; 2012; 49(2):160-8. PubMed ID: 22285953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II.
    Deng A; Miracle CM; Suarez JM; Lortie M; Satriano J; Thomson SC; Munger KA; Blantz RC
    Kidney Int; 2005 Aug; 68(2):723-30. PubMed ID: 16014049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.